Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CASS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZFHX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NRIP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAML3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK38L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM235 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OTULIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLIN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIR2DS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GUSBP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDCP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GID4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WNK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASGEF1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTGDS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on